Wednesday 21 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 3 month ago

Biogen s pricey muscle drug Spinraza too costly for Britain

Biogen s muscle disease treatment Spinraza has been deemed too expensive for use on Britain s state-run health service, even after a price discount offered by the U.S. drugmaker.

Related news

Latest News
Hashtags:   

Biogen

 | 

pricey

 | 

muscle

 | 

Spinraza

 | 

costly

 | 

Britain

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources